A naturalistic study of galantamine for Alzheimer's disease (Q42600855)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 2006

edit

Language	Label	Description	Also known as
English	A naturalistic study of galantamine for Alzheimer's disease	scientific article published on January 2006

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17044730

retrieved

3 November 2017

title

A naturalistic study of galantamine for Alzheimer's disease (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17044730

retrieved

3 November 2017

main subject

Alzheimer's disease

0 references

author

Henry Brodaty

series ordinal

1

object named as

Henry Brodaty

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17044730

retrieved

3 November 2017

author name string

Michael Woodward

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17044730

retrieved

3 November 2017

Karyn Boundy

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17044730

retrieved

3 November 2017

Nicola Barnes

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17044730

retrieved

3 November 2017

Gabrielle Allen

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17044730

retrieved

3 November 2017

NATURE Investigators

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17044730

retrieved

3 November 2017

publication date

1 January 2006

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17044730

retrieved

3 November 2017

published in

CNS Drugs

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17044730

retrieved

3 November 2017

volume

20

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17044730

retrieved

3 November 2017

issue

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17044730

retrieved

3 November 2017

page(s)

935-943

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17044730

retrieved

3 November 2017

cites work

A new rating scale for Alzheimer's disease.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2165%2F00023210-200620110-00006

retrieved

21 January 2018

A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2165%2F00023210-200620110-00006

retrieved

21 January 2018

Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2165%2F00023210-200620110-00006

retrieved

21 January 2018

Global prevalence of dementia: a Delphi consensus study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17044730

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 6-month open-label study of the effectiveness and tolerability of galantamine in patients with Alzheimer's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17044730

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Galantamine: therapeutic effects beyond cognition

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17044730

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholinesterase inhibitors for Alzheimer's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17044730

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential efficacy of treatment with acetylcholinesterase inhibitors in patients with mild and moderate Alzheimer's disease over a 6-month period.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17044730

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17044730

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

“Mini-mental state”

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17044730

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of older people: self-maintaining and instrumental activities of daily living

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17044730

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction of behavioral disturbances and caregiver distress by galantamine in patients with Alzheimer's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17044730

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17044730

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Galantamine: a review of its use in Alzheimer's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17044730

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.2165/00023210-200620110-00006

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17044730

retrieved

3 November 2017

Dimensions Publication ID

1013606931

0 references

PubMed publication ID

17044730

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17044730

retrieved

3 November 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42600855&oldid=2205526543"